For the Inventor, By the Inventor

Enter assignee name

Glenmark Pharmaceuticals Limited

USPTO Granted Patents = 33

EPO Patents = 9

Trademarks = 1

Forward Citations = 89

Loading Chart...

Loading Chart...

120 inventors (with patents filed for the assignee):

Shekhar Bhaskar Bhirud (19 out of 28 patents)

Samir Naik (7 out of 10 patents)

Sachin Srivastava (5 out of 5 patents)

4. Ulhas R Dhuppad (4 out of 22 patents)

5. Kumar Hari Bhushan (4 out of 6 patents)

6. Sushanta Mishra (4 out of 5 patents)

7. Sukumar Sinha (3 out of 8 patents)

8. Rajesh Ankam (3 out of 12 patents)

9. Suresh Babu Narayanan (3 out of 3 patents)

10. Bobba Venkata Siva Kumar (3 out of 4 patents)

11. Batchu Chandrasekhar (3 out of 3 patents)

12. Michael Crick (3 out of 3 patents)

13. Ashok Katkurwar (2 out of 11 patents)

14. Julianne Berry (2 out of 4 patents)

15. Dilipkumar Jibhau Patil (2 out of 2 patents)

33 patents: Sort by Forward Citations

1. 12514996 - Metered dose inhalers of fluticasone or an ester thereof (2026-01-06),

2. 12514995 - Metered dose inhalers of fluticasone or an ester thereof (2026-01-06),

3. 12502489 - Metered dose inhaler for ipratropium bromide solution (2025-12-23),

4. D914095 - Label (2021-03-23),

5. 10357622 - Dry powder inhaler (2019-07-23),

6. 10138206 - Amorphous form of lomitapide mesylate (2018-11-27),

7. 10138190 - Process for preparation of ospemifene (2018-11-27),

8. 10125115 - Process for the preparation of efinaconazole (2018-11-13),

9. 10106483 - Process for preparation of azelaic acid (2018-10-23),

10. 9840456 - Process for preparation of dimethyl fumarate (2017-12-12),

11. D804015 - Inhaler (2017-11-28),

12. 9776985 - Process for preparation of alogliptin (2017-10-03),

13. D797920 - Inhaler (2017-09-19),

14. 9695159 - Process for preparation of canagliflozin (2017-07-04),

15. 9670160 - Process for the preparation of tofacitinib and intermediates thereof (2017-06-06),

Glenmark Pharmaceuticals Limited is a global pharmaceutical company that focuses on developing, manufacturing, and marketing innovative and affordable solutions to address critical healthcare needs. With a presence in over 80 countries, Glenmark is committed to improving the quality of life for patients by delivering high-quality and cost-effective medicines. The company specializes in areas such as dermatology, respiratory, oncology, and generics, striving to make a positive impact on healthcare globally.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 13 2026

33 Patents

#11 in Mumbai

#61 in India

#19,593 in the World

Glenmark Pharmaceuticals Limited

Forward Citations = 89

120 inventors:

Shekhar Bhaskar Bhirud (19 out of 28 patents)

Samir Naik (7 out of 10 patents)

Sachin Srivastava (5 out of 5 patents)

4. Ulhas R Dhuppad (4 out of 22 patents)

5. Kumar Hari Bhushan (4 out of 6 patents)

Please report any incorrect information to support@idiyas.com

Loading…